Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 30, 2013
Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody j591 in men with metastatic castration-resistant prostate cancer.
Journal: Frontiers in oncology
Published: May 02, 2013
PSMA-targeted dendrimers: a patent evaluation (WO2012078534).
Journal: Expert opinion on therapeutic patents
Published: April 16, 2013
Isolation and characterization of circulating tumor cells in prostate cancer.
Journal: Frontiers in oncology
Published: May 30, 2012
Prostate-specific membrane antigen-based imaging.
Journal: Urologic oncology
Published: February 14, 2012
Osteonecrosis of jaw with the use of denosumab.
Journal: Journal of cancer research and therapeutics
Published: January 25, 2012
Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy.
Journal: Advances in urology
Published: December 15, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026